The NAFLD model induced by a HFD simulates the symptoms of human NAFLD with the accumulation of serum TG, TC, LDL-C, AST, ALT, GLU, and MCP-1 as well as hepatic steatosis. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.